AKT1 and lung cancer: Interestingly, ALK rearrangement in lung cancer, via augmented PI3K/AKT pathway activation, have been associated to an important expression and activation of HK2), a key enzyme of the glycolysis, that contributes to high glucose usage via aerobic glycolysis (117).